C.D.C. Scales Back Recommendations for R.S.V. Vaccine

Health
By Apoorva Mandavilli from NYT Health https://ift.tt/Yrtox5K
via IFTTT your-feed-science, Vaccination and Immunization, Disease Rates, Guillain-Barre Syndrome, Respiratory Syncytial Virus (RSV), Respiratory Diseases Fewer Americans age 60 to 74 should receive the shots, the agency concluded, citing reduced risks and a possible neurological side effect.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda